MGO One Seven’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.79M | Sell |
16,628
-2,774
| -14% | -$298K | 0.06% | 364 |
|
2025
Q1 | $1.96M | Buy |
19,402
+892
| +5% | +$90K | 0.08% | 285 |
|
2024
Q4 | $1.65M | Sell |
18,510
-568
| -3% | -$50.7K | 0.06% | 312 |
|
2024
Q3 | $1.6M | Buy |
19,078
+2,406
| +14% | +$202K | 0.07% | 287 |
|
2024
Q2 | $1.28M | Buy |
16,672
+8,399
| +102% | +$647K | 0.06% | 321 |
|
2024
Q1 | $567K | Sell |
8,273
-638
| -7% | -$43.7K | 0.03% | 484 |
|
2023
Q4 | $515K | Buy |
8,911
+411
| +5% | +$23.8K | 0.03% | 510 |
|
2023
Q3 | $449K | Sell |
8,500
-357
| -4% | -$18.9K | 0.03% | 474 |
|
2023
Q2 | $479K | Buy |
8,857
+45
| +0.5% | +$2.43K | 0.04% | 426 |
|
2023
Q1 | $441K | Buy |
8,812
+3,105
| +54% | +$155K | 0.03% | 520 |
|
2022
Q4 | $264K | Buy |
5,707
+89
| +2% | +$4.12K | 0.03% | 593 |
|
2022
Q3 | $217 | Buy |
5,618
+54
| +1% | +$2 | 0.01% | 629 |
|
2022
Q2 | $207K | Sell |
5,564
-4,217
| -43% | -$157K | 0.03% | 568 |
|
2022
Q1 | $433K | Buy |
9,781
+51
| +0.5% | +$2.26K | 0.05% | 405 |
|
2021
Q4 | $413K | Buy |
9,730
+2,423
| +33% | +$103K | 0.04% | 415 |
|
2021
Q3 | $315K | Buy |
7,307
+83
| +1% | +$3.58K | 0.04% | 439 |
|
2021
Q2 | $309K | Buy |
7,224
+1,489
| +26% | +$63.7K | 0.04% | 441 |
|
2021
Q1 | $221K | Buy |
+5,735
| New | +$221K | 0.04% | 484 |
|
2020
Q4 | – | Sell |
-6,210
| Closed | -$237K | – | 499 |
|
2020
Q3 | $237K | Sell |
6,210
-1,346
| -18% | -$51.4K | 0.06% | 384 |
|
2020
Q2 | $265K | Buy |
+7,556
| New | +$265K | 0.07% | 351 |
|
2019
Q1 | – | Sell |
-791
| Closed | -$27K | – | 569 |
|
2018
Q4 | $27K | Buy |
+791
| New | +$27K | 0.01% | 808 |
|
2018
Q1 | $21K | Hold |
759
| – | – | 0.01% | 848 |
|
2017
Q4 | $19K | Buy |
+759
| New | +$19K | 0.01% | 873 |
|